Cobenfy | World Briefings

FDA Approves New Schizophrenia Drug: A Breakthrough After Decades of Limited Options

Health

FDA Approves New Schizophrenia Drug: A Breakthrough After Decades of Limited Options

Sept. 27, 2024 – In a breakthrough for people living with schizophrenia, the FDA has approved a new oral medication...

FDA Approves Cobenfy: First New Schizophrenia Treatment in 70 Years

Health

FDA Approves Cobenfy: First New Schizophrenia Treatment in 70 Years

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s...

News Categories

Follow Us